Independent COA certificates · Delivery in 1–3 business days · Cash on delivery

Research Hub

GHK-Cu: What the Research Says

What GHK-Cu Is GHK-Cu is a complex formed between the naturally occurring human tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys) and a divalent copper…

Continue reading →

Melanotan 2: What the Research Says

What Melanotan 2 Is Melanotan II (MT-2) is a synthetic cyclic analogue of α-melanocyte-stimulating hormone (α-MSH). It was developed in…

Continue reading →

PT-141: What the Research Says

What PT-141 Is PT-141, international non-proprietary name bremelanotide, is a cyclic heptapeptide derived directly from Melanotan II. It was in…

Continue reading →

Epitalon: What the Research Says

What Epitalon Is Epitalon (epithalon, AEDG) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It was created by Professor Vladimir…

Continue reading →

NAD+: What the Research Says

What NAD+ Is Nicotinamide adenine dinucleotide (NAD+) is not a peptide but a coenzyme present in every living cell, and…

Continue reading →

MOTS-c: What the Research Says

What is MOTS-c? MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid peptide with an unusual…

Continue reading →

BPC-157 vs TB-500: Differences, Mechanisms and Why They Are Combined

BPC-157 and TB-500 are the two most widely discussed regenerative peptides in the preclinical literature. They are frequently mentioned in…

Continue reading →

Ipamorelin vs CJC-1295: The Difference and Why Researchers Combine Them

Ipamorelin and CJC-1295 are the two most-studied peptides of the GH-secretagogue family — molecules that stimulate growth hormone (GH) release…

Continue reading →

NAD+ vs NMN: What the Science Says About Cellular Energy

NAD+ and NMN are the two most-discussed molecules in ageing and cellular-metabolism research. One is the coenzyme itself, without which…

Continue reading →

Ozempic vs Mounjaro: Differences, Results, Prices [2026]

Ozempic and Mounjaro are the two most talked-about injectable medications of the decade — both originally developed for type 2…

Continue reading →